Publication | Closed Access
Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 2. Imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamides
38
Citations
0
References
1980
Year
Antiparasitic AgentPharmacotherapyChemical BiologyThrombosisMedicinal ChemistryNeurologyInhibitory ActivityEnzyme Carbonic AnhydraseSelective InhibitionBiochemistryPharmacological AgentNeuropharmacologyCerebral Blood FlowPharmacologyNatural SciencesAnticonvulsant Ed50Metabolic AcidosisCentral Nervous SystemMedicineDrug Discovery
A series of imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamide carbonic anhydrase inhibitors is described and their anticonvulsant activities are listed. Many of the compounds have the same degree of ionization as acetazolamide and methazolamide, but their higher lipophilicity means that they are more able to penetrate into the central nervous system. One compound, 6-tert-butyl-2-sulfamoylimidazo[2,1-b]-1,3,4-thiadiazole (8, UK-15,454) had an anticonvulsant ED50 of 2.6 mg/kg when administered orally to mice. 8 selectively increased cerebral blood flow in animals without producing a high level of metabolic acidosis.